Properties

Melting point:150-152°C

Density 1.372

storage temp. Sealed in dry,Store in freezer, under -20°C

solubility DMSO (Slightly), Methanol (Slightly, Heated)

form Solid

pka11.84±0.46(Predicted)

color White to Off-White

Avanafil API pharmaceutical export

Avanafil API pharmaceutical wholesaler

Shortage Avanafil API Supplies

supply of various Avanafil API

Avanafil API Import and Export Wholesaler

wholesale distribution of Avanafil API

Avanafil API DISTRIBUTION CHANNELS

Wholesaler Distributor Licensure of Avanafil API

Certificate of Analysis (COA) for Avanafil API

Valid Avanafil API GMP certification

Valid Avanafil API Manufacturing License

Method of Analysis for Avanafil API

Material safety data sheet for Avanafil API

Accelerated stability data for Avanafil API

Real time stability data for Avanafil API

Avanafil API Exporters and Contract manufacturing

Avanafil in USP, BP, EP with DMF, Tech Pack, GMP, Written Confirmation

Regulatory Documents of Avanafil

Avanafil  API of manufacturers who are USFDA audited & accredited with GMP, ISO

Avanafil with DMF/GMP/ISO (all technical documents support)

Avanafil  API in USP/BP/EP pharmacopoeia

Avanafil  Micronised, Injection, & all grades

Avanafil  API factory accredited by USFDA, Health Canada, TGA, UK-MHRA, PIC/S

Avanafil  API with cGMP manufacturing facility、GMP certified facility

Avanafil  API with GLP certified laboratory

Avanafil  API with cGMP & WHO GMP compliant facility

Avanafil  API with R&D and Commercial quantity

Dosage form of Avanafil  API

Avanafil  API U.sPharmacopeia (UsP), in-house specification and/or European Pharmacopoeia (Ph. Eur) 

Avanafil  API distributor with a strong supply chain channel

Avanafil  API Provide CEP/COS(certificate of suitability to monograph of European Pharmacopoeia)  , EDMF(European Drug Master File),and GMP(Good Manufacturing Practice ),Written Confirmation.

Avanafil  API certificate of analysis

Avanafil  API factory GMP (Goods Manufacturing Practices Certificate ) 

Avanafil  API Product DML (Drug Manufacturing License)

    Developed by Japan's Tanabe Pharmaceutical Company and VIVUS, it was approved for listing in the United States on April 27, 2012. This product is a type 5 phosphodiesterase (PDE5) inhibitor, which can increase the blood flow of the penis. It is currently the first-line drug for the treatment of ED. The first-line drug for the treatment of ED includes sildenafil and vardenafil ), tadalafil (tadalafil) and avanafil (avanafil). As a second-generation PDE5 inhibitor, avanafil has the characteristics of fast onset and short duration, and increases the selectivity of PDE5 isoenzymes, which plays an important role in reducing the incidence of adverse reactions. Studies have shown that the drug can take effect in just 15 minutes, which is faster than 30-60 minutes reported by other drugs, and eating can affect the pharmacokinetics of sildenafil and vardenafil, but does not affect alva That's not. The rapid onset of avanafil allows ED patients to enjoy sex freely without having to take medication too early. It is a strong competitor of sildenafil (Viagra).

    Hot Tags: Avanafil API, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tippyridine Hydrochloride API, Lercanidipine Hydrochloride API, Temozolomide API, Dimethyl Fumarate API, Rasagiline Mesylate API, Pleasant API